DIA

DIA’s training schedule is for 2025 is here! Gain the skills and knowledge you need with expert-led courses designed for your professional growth. Explore upcoming virtual and in-person training opportunities across key areas of expertise. Swipe to see the full schedule and heck out our website for more details: https://bit.ly/4fShPfn. Karin Gamba-Blessing #DIALearning #ProfessionalDevelopment #TrainingCourses

Final Call: DIA MENA Conference 2024 We are proud to announce that leading regulators from across the Middle East & North Africa (MENA) region will be joining the DIA MENA Conference 2024 next week in Cairo. These esteemed experts will address critical regional challenges, share insights on regulatory developments, and present future priorities to shape the healthcare landscape. This is a unique opportunity to engage directly with health authority representatives, gain firsthand knowledge of regulatory innovations, and collaborate on advancing medicinal product development across the region. ?? Date: 26–27 November ?? Location: Cairo, Egypt Don’t miss the last chance to register: https://bit.ly/3X4ghrA. #DIAMENA2024 #Collaboration #LifeSciences #RegulatoryAffairs

We are excited to announce our partnership with the US FDA to bring you the DIA-US FDA Biosimilars Conference on 3-4 February 2025 in Hyderabad, India. This joint program offers a unique opportunity to hear from FDA subject matter experts on current regulatory perspectives on various topics related to biosimilar application life-cycle management including:? ? Biosimilar review process ? FDA data expectations ? Interchangeability ? Common review deficiencies ? Post approval changes ? Inspections and observations ? Best practices and real-world examples Join us for valuable insights and strategies to navigate the evolving biosimilars landscape with experts from regulatory, industry and academia. Save the date (https://bit.ly/4fq2eDn) and stay tuned for more details! #DIAUSFDA2025 #Biosimilars #RegulatoryAffairs #Biotech #Pharmaceuticals

What Does DIA Mean to You? The DIA Global Annual Meeting 2024 brought together industry leaders and professionals from around the world. With expert speakers, cutting-edge discussions, and a wealth of networking opportunities, the 2024 event was nothing short of transformative. Join us as we reflect on inspiring conversations and forward-thinking ideas shared at DIA 2024 and make a plan to share your voice at DIA 2025.https://ow.ly/s02b50U0BFe

Are you interested in the evolving landscape of pharmacovigilance? Join our ‘Artificial Intelligence in Pharmacovigilance’ training course to learn about the latest technological advancements in this field. In this course, we will cover: ? How pharmacovigilance and its technologies are changing. ? Various AI technologies, including ChatGPT. ? Management perspectives and challenges, including people, skills, governance, audits, and compliance. ? Current PV IT platforms and their capabilities in AI and automation. ? Envisioning the ideal PV IT intelligence system of the future. Register by 10 December to benefit from the early bird rate: https://bit.ly/48TZLi2. Jan Petracek Phil Tregunno Robert Scheiner Karin Gamba-Blessing #Pharmacovigilance #DrugSafety #IT #ArtificialIntelligence #AI

Ready to expand your knowledge, connect with industry leaders, and elevate your impact in life sciences? Our event lineup includes dynamic specialty and annual meetings designed to keep you at the forefront of regulatory updates, innovative solutions, and networking opportunities. Don’t miss out on your chance to grow with the life sciences community! ?? Take a look at a few of our upcoming events: Webinar: Inclusivity as a Part of Feasibility: Making Trials More Representative with RWD https://ow.ly/IpSq50U8Uni November 19 | 12:00PM-1:00PM | Virtual Webinar: Polaris by OM1: Clinical Trial Recruitment for Faster, Cost-Effective Trials https://ow.ly/Jkzp50U8Ulp November 19 | 2:00PM-3:00PM | Virtual Global Pharmacovigilance and Risk Management Strategies Conference https://ow.ly/RTWF50U8UqJ January 27-29 | Baltimore, MD Regulatory Submissions, Information, and Document Management Forum https://ow.ly/6nSZ50U8Ut4 February 3-5 | North Bethesda, MD Advertising and Promotion Regulatory Affairs Conference https://ow.ly/w9V750U8Uuk February 24-25 | Bethesda, MD Medical Affairs and Scientific Communications Forum https://ow.ly/jFyC50U8Ug3 March 10-12 | Boston, MA Global Labeling Conference https://ow.ly/RwZz50U8Uyh April 7-8, 2025 | Arlington, VA

Join your fellow regulatory policy leaders, senior decision makers, and regulators in the pharmaceutical community for this two-day, highly interactive summit that will convene 3-4 December at the Radisson Grand Place in Brussels. We’ll be discussing top solutions and next steps towards a more vibrant and patient-centric pharmaceutical landscape. We’re proud of our partnership with Regulatory Affairs Professionals Society (RAPS) and look forward to this collaborative event. We invite you to register today: https://bit.ly/3YMFisn.

?? ?? ?????? ???????????? ???????? ?????????? ??????????! We are delighted to share that the DIA Global QPPV Forum, held earlier this month in Amsterdam, was a resounding success with over 150 attendees! This event gathered industry leaders, QPPVs, and pharmacovigilance experts from all over the world to discuss key issues and exchange ideas that are shaping the future of drug safety. A big thank you to all attendees, speakers, and the programme committee for making this forum possible. Looking ahead, we are excited to announce that the next edition of the DIA Global QPPV Forum is set for 18-20 November 2025! Sign up now to be among the first to receive updates and important announcements: https://bit.ly/4esS1oh. Reflecting on this year’s forum, here are some of the key takeaways: ? The role of the QPPV remains crucial as the advocate for patient safety, with ongoing challenges in navigating interfaces and adapting to new therapeutic modalities like gene therapy and combination products. ? Embracing new technologies and staying updated on developments such as ecopharmacovigilance are essential for future-proofing pharmacovigilance efforts. ? Effective communication and collaboration between EU and local QPPVs, vendors, and safety teams are important for maintaining compliance and ensuring comprehensive oversight. ? Regulatory alignment and transparent partnerships between inspectorates and MAHs can streamline processes and inspections, leading to better compliance and strategic outcomes. ? Automation and generative AI hold potential for enhancing efficiency in pharmacovigilance, but should be carefully balanced with the necessary validation and regulatory evidence to mitigate risks. Thank you again for making this year’s forum such a success. We look forward to continuing to drive progress and innovation within the pharmacovigilance community. Gemma Jiménez Sesé Maarten Lagendijk Angela van der Salm Shahinaz Badr Vicki Edwards Magnus Ysander Elspeth McIntosh Katarzyna (Kasia) ?widerek Claire Longman Willemijn van der Spuij Cláudia Ferreira Sonia E. Lo Dolce (Martinez) #QPPV #Pharmacovigilance #DrugSafety

Did you miss out on the early bird rates for DIA Europe 2025? Don’t worry, we have you covered. Group and advanced rates are now available! Join us from 18-20 March in Basel, Switzerland, for an exceptional experience in the pharmaceutical and life sciences sector. Key highlights: ? Engage with global regulators, including the FDA, EMA, and European Commission. ? Benefit from 3 days of in-person insights with an additional 3 months of digital access. ? Attend 6 DIAmond Sessions covering vital topics such as sustainability and digital transformation. ? Participate in 50+ interactive sessions and network with over 1500 professionals. ? Discover 70+ exhibitors showcasing the latest innovations. Hear from Joseph Scheeren, DIA Fellow, on why DIA Europe is such an important meeting in the life sciences sector. Secure your spot today: https://bit.ly/4aN1NA1. #DIAEurope2025 #Healthcare #LifeSciences #Conference #Innovation

Advance your career in medical devices and drug-device combination products by joining our exclusive Post-Market Surveillance (PMS) and Clinical Evidence workshop. Learn how to establish a PMS system, tackle challenges, and explore opportunities with insights from notified bodies, regulatory authorities, and industry experts. Plus, take advantage of the Q&A session to ask your questions! Don't miss this opportunity to stay ahead of the curve. Register now: https://bit.ly/3XTY7tq. Leon Doorn Josep Pané Milo? Stojkovi? Glory Msacky, MD Anna Amich Robert Di Giovanni Taylor Dieringer Surash Surash Harminder Mudhar Karin Gamba-Blessing #DIALearning #TrainingCourse #MedicalDevices #CombinationProducts #PMS?